Deborah L. Weitzman

Deborah L. Weitzman

Chief Executive Officer, Pharmaceutical and Specialty Solutions SegmentatCardinal Health· In proxies 2023–2026

Pay in FY2026+11% from the year before

Deborah L. Weitzman was paid $6.1M in FY2026 (Jun), up 11%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Cardinal Health proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Cardinal HealthPublic company · 3 yr
    • Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?